RANDOMISED, PLACEBO-CONTROLLED, LONG-TERM STUDY OF RISPERIDONE LONG ACTING INJECTABLE IN RELAPSE PREVENTION IN BIPOLAR DISORDER PATIENTS

被引：0
|
作者：
Quiroz, Jorge [1 ]
Palumbo, Joseph [1 ]
Karcher, Keith [1 ]
Kushner, Stuart [1 ]
Kusumakar, Vivek [1 ]
Yatham, Lakshmi [1 ]
机构：
[1] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
来源：
BIPOLAR DISORDERS | 2009年 / 11卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：785 / 785
页数：1
相关论文
共 50 条
  • [1] Randomized, placebo-controlled, long-term study of risperidone long-acting injectable in relapse prevention in bipolar I disorder patients
    Quiroz, J. A.
    Yatham, L. N.
    Palumbo, J. M.
    Karcher, K.
    Kushner, S.
    Kusumakar, V.
    [J]. BIPOLAR DISORDERS, 2009, 11 : 71 - 71
  • [2] RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF RISPERIDONE LONG-ACTING INJECTABLE IN RELAPSE PREVENTION IN PATIENTS WITH BIPOLAR I DISORDER
    Montgomery, S.
    Vieta, E.
    Sulaiman, A. H.
    Cordoba, R.
    Huberlant, B.
    Schreiner, A.
    Martinez, G.
    [J]. EUROPEAN PSYCHIATRY, 2010, 25
  • [3] A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone
    Vieta, Eduard
    Nieto, Evaristo
    Autet, Aurea
    Rosa, Adriane R.
    Goikolea, Jose M.
    Cruz, Nuria
    Bonet, Pere
    [J]. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2008, 9 (03): : 219 - 224
  • [4] A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder
    Vieta, Eduard
    Montgomery, Stuart
    Sulaiman, Ahmad Hatim
    Cordoba, Rodrigo
    Huberlant, Benedicte
    Martinez, Lupe
    Schreiner, Andreas
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 (11) : 825 - 835
  • [5] Long-term safety and tolerability of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder
    Lindenmayer, Jean-Pierre
    Khan, Akbar
    Eerdekens, Marielle
    Van Hove, Ilse
    Kushner, Stuart
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 (02) : 138 - 144
  • [6] LONG-TERM REMISSION IN SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER: RESULTS FROM THE RISPERIDONE LONG-ACTING INJECTABLE VERSUS QUETIAPINE RELAPSE PREVENTION TRIAL (CONSTATRE)
    Smeraldi, E.
    Cavallaro, R.
    Smalc, V. Folnegovic
    Bidzan, L.
    Ceylan, E.
    Schreiner, A.
    Lex, A.
    [J]. EUROPEAN PSYCHIATRY, 2009, 24
  • [7] Long-term remission in schizophrenia and schizoaffective disorder: results from the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE)
    Smeraldi, Enrico
    Cavallaro, Roberto
    Folnegovic-Smalc, Vera
    Bidzan, Leszek
    Ceylan, Mehmet Emin
    Schreiner, Andreas
    [J]. THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2013, 3 (04) : 191 - 199
  • [8] Long-acting, injectable risperidone in frequently relapsing bipolar disorder
    Bain, E.
    Kujawa, M.
    Mahmoud, R.
    Adler, C.
    Turkoz, I.
    Gharabawi, G.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S276 - S277
  • [9] Does Long-Acting Injectable Risperidone (RLAI) Reduce Relapse and Rehospitalization in Patients with Frequently Relapsing Bipolar Disorder?
    Bobo, William V.
    Epstein, Richard A.
    Lynch, Alan
    Patton, Tynya D.
    Bossaller, Nicholas A.
    Shelton, Richard C.
    [J]. BIOLOGICAL PSYCHIATRY, 2011, 69 (09) : 37S - 37S
  • [10] A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently
    Macfadden, Wayne
    Alphs, Larry
    Haskins, J. Thomas
    Turner, Norris
    Turkoz, Ibrahim
    Bossie, Cynthia
    Kujawa, Mary
    Mahmoud, Ramy
    [J]. BIPOLAR DISORDERS, 2009, 11 (08) : 827 - 839
12345